Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas ; volume:7 ; number:1 ; day:25 ; month:9 ; year:2017 ; pages:1-10 ; date:12.2017
Scientific reports ; 7, Heft 1 (25.9.2017), 1-10, 12.2017
- Urheber
-
Dai, Yu-Jie
- Beteiligte Personen und Organisationen
-
Qiu, Yi-Bo
Jiang, Rong
Xu, Man
Zhao, Le
Chen, George G.
Liu, Zhi-Min
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-12478-1
- URN
-
urn:nbn:de:101:1-2018082913373215036676
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dai, Yu-Jie
- Qiu, Yi-Bo
- Jiang, Rong
- Xu, Man
- Zhao, Le
- Chen, George G.
- Liu, Zhi-Min
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
The expression of stromal biomarkers in small papillary thyroid carcinomas
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
EGFR Expression in HER2-Driven Breast Cancer Cells
EGFR und HER2-neu-Expression im oralen Plattenepithelkarzinom
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
The expression of stromal biomarkers in small papillary thyroid carcinomas
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
EGFR Expression in HER2-Driven Breast Cancer Cells
EGFR und HER2-neu-Expression im oralen Plattenepithelkarzinom
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
The expression of stromal biomarkers in small papillary thyroid carcinomas
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
EGFR Expression in HER2-Driven Breast Cancer Cells
EGFR und HER2-neu-Expression im oralen Plattenepithelkarzinom
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion